Table 3.
Clinical outcomes.
| Outcomes | Study group (n = 158) | Control group (n = 158) | p Value | Odds ratio (95% CI) |
|---|---|---|---|---|
| N (%) | N (%) | |||
| Primary outcome | ||||
| Biochemical pregnancy | 63 (39.9) | 66 (41.8) | 0.73 | 0.92 (0.59, 1.45) |
| Clinical pregnancy | 54 (34.2) | 50 (31.7) | 0.63 | 1.12 (0.70, 1.79) |
| Secondary outcomes | ||||
| Implantation rate | 24.8 | 21.4 | 0.35 | 1.21 (0.81, 1.82) |
| Ongoing pregnancy rate | 53 (33.5) | 48 (30.4) | 0.55 | 1.16 (0.72, 1.86) |
| Miscarriage rate | 15 (9.5) | 30 (19.1) | 0.02† | 0.44 (0.23, 0.86) |
| Ectopic pregnancy | 1 (0.7) | 1 (0.6) | 0.95 | – |
| Multiple pregnancies | 12 (7.6) | 6 (3.8) | 0.15 | 2.08 (0.76, 5.69) |
| Live birth rate | 48 (30.4) | 36 (22.8) | 0.13 | 1.48 (0.89, 2.45) |
The chemical pregnancy rate, clinical pregnancy rate, implantation rate, ongoing pregnancy rate, ectopic pregnancy rate, multiple pregnancies, and live birth rate were comparable between the groups. However, the miscarriage rate of the total study population was significantly lowered in the study group.